StonvexLoading…
StonvexStonvexStonvexCore line items from ATRO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $862.13M | $795.43M | $689.21M | $534.89M |
Operating Income | $76.41M | $26.47M | $-6.67M | $-30.04M |
Net Income | $29.36M | $-16.21M | $-26.42M | $-35.75M |
EPS (Diluted) | $0.81 | $-0.46 | $-0.80 | $-1.11 |
Total Assets | $706.68M | $648.76M | $633.79M | $615.03M |
Total Liabilities | $566.60M | $392.67M | $384.27M | $375.11M |
Cash & Equivalents | $18.18M | $9.29M | $4.76M | $13.78M |
Free Cash Flow OCF − CapEx | $43.12M | $22.14M | $-31.59M | $-35.99M |
Shares Outstanding | 36.46M | 35.04M | 33.10M | 32.16M |